Home > Journals > Minerva Biotechnology and Biomolecular Research > Past Issues > Minerva Biotechnology and Biomolecular Research 2021 June;33(2) > Minerva Biotechnology and Biomolecular Research 2021 June;33(2):51-2

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL  BIOTECHNOLOGICAL AND PHARMACOLOGICAL DEVELOPMENTS IN THE MODIFICATION OF CHRONIC INFLAMMATION-INDUCED DISEASES Freefree

Minerva Biotechnology and Biomolecular Research 2021 June;33(2):51-2

DOI: 10.23736/S2724-542X.21.02803-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Hot topics in chronic inflammation-induced diseases at the time of COVID-19

Tetyana FALALYEYEVA 1 , Rinaldo PELLICANO 2

1 Educational and Scientific Center Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 2 Unit of Gastroenterology, Molinette Hospital, Turin, Italy



top of page